Hamilton Lane Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Hamilton Lane Advisors’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-44,376	Closed	-$1M	–	63
2015 Q4	$1M	Buy	44,376 +411	+0.9%	+$8.42K	0.44%	33
2015 Q3	$729K	Hold	43,965	–	–	0.36%	40
2015 Q2	$989K	Buy	43,965 +10,120	+30%	+$250K	0.37%	43
2015 Q1	$873K	Buy	+33,845	New	+$858K	0.4%	30
2014 Q2	–	Sell	-6,073	Closed	-$204K	–	80
2014 Q1	$204K	Buy	+6,073	New	+$205K	0.08%	62

Other funds holding OMED

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Hamilton Lane Advisors's OMED Position: Q1 2016 in Review

Hamilton Lane Advisors sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q1 2016, closing a stake of 44,376 shares — an estimated $1M sold.

Hamilton Lane Advisors first reported a position in OMED in Q1 2014 and held it in 5 quarters. The position peaked at $1M in Q4 2015. 83 funds tracked by Wall St. Rank hold OMED as of Q1 2016.

Hamilton Lane Advisors reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Hamilton Lane Advisors sold 44,376 OncoMed Pharmaceuticals, Inc. shares in Q1 2016, an estimated $1M.
Hamilton Lane Advisors first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2014 and held it in 5 quarters.
Hamilton Lane Advisors's OncoMed Pharmaceuticals, Inc. position peaked at $1M in Q4 2015.
83 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q1 2016.

Based on Hamilton Lane Advisors's 13F filing for Q1 2016, filed 13 Apr 2016.